Who Exports Fexofenadine from India — 224 Suppliers Behind a $109.6M Market
India's fexofenadine export market is supplied by 224 active exporters who collectively shipped $109.6M across 4,236 shipments. GRANULES INDIA LIMITED leads with a 16.1% market share, followed by IND SWIFT LIMITED and CIPLA LIMITED. The top 5 suppliers together control 62.4% of total export value, reflecting a concentrated market structure.
Top Fexofenadine Exporters from India — Ranked by Export Value
GRANULES INDIA LIMITED is the leading fexofenadine exporter from India, holding a 16.1% share of the $109.6M market across 4,236 shipments from 224 exporters. The top 5 suppliers — GRANULES INDIA LIMITED, IND SWIFT LIMITED, CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED — collectively control 62.4% of total export value, indicating a moderately concentrated market. Individual shares are: GRANULES INDIA LIMITED (16.1%), IND SWIFT LIMITED (13.3%), CIPLA LIMITED (12.4%), DR.REDDY'S LABORATORIES LTD (11.5%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (9.1%).
Top Fexofenadine Exporters from India
Ranked by export value · 224 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE HYDROCHLORIDE TABLETS | $17.7M | 1 | 16.1% |
| 2 | IND SWIFT LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $14.6M | 12 | 13.3% |
| 3 | CIPLA LIMITED FEXOFENADINE 120MG TABS PACK SIZE 10 X 10FEXOFENADINE 180MG TABS PACK SIZE 10 X 10FEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $13.6M | 7 | 12.4% |
| 4 | DR.REDDY'S LABORATORIES LTD FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $12.6M | 5 | 11.5% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE HYDROCHLORIDE TABLETS | $10.0M | 7 | 9.1% |
| 6 | DR REDDYS LABORATORIES LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $6.1M | 3 | 5.6% |
| 7 | MEDREICH LIMITED FEXOFENADINE 180MG TABLETS PACK SIZE 3X10SFEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30SFEXOFENADINE 180MG FILM-COATED TABLETS 3 | $5.7M | 6 | 5.2% |
| 8 | LYRUS LIFE SCIENCES PRIVATE LIMITED FEXOFENADINE 180MG TABLETS PACK SIZE 3X10SFEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30SFEXOFENADINE 180MG FILM-COATED TABLETS 3 | $4.3M | 1 | 4.0% |
| 9 | MICRO LABS LIMITED FEXIGRA 120 TABLETS (FEXOFENADINE HYDROC | $2.4M | 14 | 2.2% |
| 10 | DR REDDY S LABORATORIES LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $2.4M | 3 | 2.1% |
| 11 | IND-SWIFT LIMITED FEXOFENADINE 180MG TABLETS PACK SIZE 3X10SFEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30SFEXOFENADINE 180MG FILM-COATED TABLETS 3 | $2.3M | 11 | 2.1% |
| 12 | DR.REDDY'S LABORATORIES LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE 180MG TABLETS PACK SIZE 3X10S | $1.7M | 2 | 1.6% |
| 13 | J B CHEMICALS AND PHARMACEUTICALS LIMITED FEXOFENADINE HYDROCHLORIDE TABLETS USP 180MGFEXOFENADINE HYDROCHLORIDE TABLETS USPFEXOFENADINE HYDROCHLORIDE TABLETS | $1.7M | 1 | 1.6% |
| 14 | ZENTIVA PRIVATE LIMITED FEXOFENADINE 180MG TABLETS PACK SIZE 3X10SFEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30SFEXOFENADINE 180MG FILM-COATED TABLETS 3 | $1.7M | 1 | 1.6% |
| 15 | CADILA PHARMACEUTICALS LIMITED TERRY WHITE CHEMMART FEXOFENADINE HAYFEVAPO HEALTH FEXOFENADINE 180 MG(FEXOFENADCHEMISTS OWN FEXO 180MG TABLET BATCH BY05E4009 TO BY05E4016 | $1.6M | 9 | 1.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Fexofenadine exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Granules India Limited | Warning Letter, February | Unknown | Unknown | Not verified | FDA issued a warning letter citing CGMP violations at the Gagillapur facility. |
| Cipla Limited | Warning Letter, November | Unknown | Unknown | Not verified | FDA issued a warning letter for CGMP violations at the Indore facility. |
| Dr. Reddy's Laboratories Ltd. | Warning Letter, June 2011 | Unknown | Unknown | Not verified | FDA issued a warning letter for CGMP violations at the Mexico facility. |
| Sun Pharmaceutical Industries Limited | Unknown | Unknown | Unknown | Not verified | No FDA warning letters found; company issued a voluntary recall in March 2025. |
| Zydus Lifesciences Limited | Warning Letter, August 20 | Unknown | Unknown | Not verified | FDA issued a warning letter for CGMP violations at the Vadodara facility. |
| Cadila Pharmaceuticals Limited | Warning Letter, 2015 | Unknown | Unknown | Not verified | FDA issued a warning letter for CGMP violations in 2015. |
TransData Nexus reviewed the regulatory standing of 6 leading Fexofenadine exporters from India. 0 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 5 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Fexofenadine sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy's Laboratories and Aurobindo Pharma. Hyderabad's Genome Valley, India's first biotech cluster, provides advanced R&D infrastructure and a skilled talent pool, contributing significantly to the city's prominence in API manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to major companies like Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's robust infrastructure, including well-developed ports and transportation networks, facilitates efficient production and export of pharmaceutical products.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, hosts numerous pharmaceutical companies with a strong focus on international markets. The region's proximity to major ports enhances its capacity for large-scale pharmaceutical exports, including formulations and APIs.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, has emerged as a significant pharmaceutical manufacturing hub, housing over 1,000 pharma units. The region's growth is largely attributed to favorable government policies, including tax incentives and exemptions, which have attracted numerous pharmaceutical companies to set up manufacturing facilities.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the technical and regulatory compliance capabilities of suppliers, especially those in Hyderabad for APIs and Ahmedabad-Vadodara for formulations.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline international shipments.
- Consider Cost Advantages: Explore manufacturing options in Baddi-Nalagarh to benefit from tax incentives and cost-effective production.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Fexofenadine exporters from India
Dr. Reddy's Laboratories Ltd. — Dr. Reddy's explores joint bid for Cipla with Bain Capital
In September 2023, Dr. Reddy's Laboratories Ltd. was approached by Bain Capital to consider a joint bid to acquire a controlling stake in Cipla Ltd. This strategic move aimed to consolidate market position and expand product portfolios. - IMPACT: If successful, this acquisition could enhance Dr. Reddy's production capabilities, potentially increasing Fexofenadine exports.
Impact: If successful, this acquisition could enhance Dr. Reddy's production capabilities, potentially increasing Fexofenadine exports.
Common Questions — Fexofenadine Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which fexofenadine supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, GRANULES INDIA LIMITED leads with 194 recorded shipments worth $17.7M. IND SWIFT LIMITED (524 shipments) and CIPLA LIMITED (921 shipments) are also established high-volume exporters.
Q How many fexofenadine manufacturers are there in India?
India has 224 active fexofenadine exporters with a combined export market of $109.6M across 4,236 shipments to 97 countries. The top 5 suppliers hold 62.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for fexofenadine from India?
Average FOB unit price: $7.89 per unit, ranging from $0.01 to $3844.45. Average shipment value: $25.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 224 verified Indian exporters of Fexofenadine ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,236 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 97 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,236 Verified Shipments
224 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists